EUVIMEDTutustu EUVIMEDiin
CrossrefTietokortti

Retrospective evaluation of the use of quick Sepsis‐related Organ Failure Assessment (qSOFA) as predictor of mortality and length of hospitalization in dogs with pyometra (2013‐2019): 52 cases

Pablo Donati, Leonel A. Londoño, Marcela Tunes, Cesar Villalta, Eliana C. Guillemi

Journal of Veterinary Emergency and Critical Care · 2022-03 · 32 (2) · 223-228

DOI: 10.1111/vec.13103 ↗
TiivistelmäBibliografiset tiedot

Tiivistelmä

Abstract Objective To evaluate the prognostic utility of quick Sepsis‐related Organ Failure Assessment (qSOFA) for prediction of in‐hospital mortality and length of hospitalization in dogs with pyometra. Design Retrospective cohort study from February 2013 to April 2019 Setting Tertiary referral hospital Animals Fifty‐two dogs referred with confirmed diagnosis of pyometra Interventions None Measurements and principal outcomes Sixty‐five percent of dogs survived to discharge. A cut‐off score of ≥2 for qSOFA was associated with in‐hospital mortality (odds ratio 6.51 [95% CI: 1.35 ‐ 31.3]) P = 0.019. The area under the receiver operator characteristic curve for a qSOFA score ≥ 2 for mortality was 0.72 (95% CI: 0.59‐0.85), with a sensitivity of 77.8% and a specificity of 66.7%. The mean ± SD number of organs with dysfunction was significantly higher in dogs with a qSOFA score ≥2 1.76 ± 0.83 compared to dogs with a qSOFA score < 2 1.08 ± 1.09, P = 0.015. The presence of a qSOFA score ≥ 2 was associated with a longer time of hospitalization in survivors with a median (interquartile range) length of stay in qSOFA < 2 (48 [33]) hours versus qSOFA score ≥ 2 (78 [52]) hours, P = 0.027. Conclusions In dogs with pyometra, the qSOFA score was associated with mortality and length of hospitalization. This score might be useful to improve the risk stratification in dogs with pyometra. Further studies are necessary to evaluate the predictive capacity of qSOFA in other septic patient populations.

Työhösi sopivaa tietoa.

Maksuttomasta aloituksesta ja henkilökohtaisesta kirjallisuushausta koko Research Suite -kokonaisuuteen.

Katso hinnat →

Sisältyvätkö kaikki kustantajien kokotekstit?

Ei. Bibliografiset viitteet, tiivistelmät ja kokotekstit ovat eri sisältöjä. Se, onko kokoteksti saatavilla, riippuu lähteestä, Open Accessista ja olemassa olevista lisensseistäsi. EUVIMED-paketti ei korvaa ylimääräisiä kustantajaoikeuksia.

Katso hinnat →